| Ticker Details |
Myomo Inc.
Myomo Inc is a medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line of lightweight, non-invasive, powered arm braces.
|
| IPO Date: |
June 12, 2017 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$28.06M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.17 | 3.91%
|
| Avg Daily Range (30 D): |
$0.02 | 2.79%
|
| Avg Daily Range (90 D): |
$0.03 | 3.59%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.36M |
| Avg Daily Volume (30 D): |
.44M |
| Avg Daily Volume (90 D): |
.72M |
| Trade Size |
| Avg Trade Size (Sh.): |
213 |
| Avg Trade Size (Sh.) (30 D): |
240 |
| Avg Trade Size (Sh.) (90 D): |
303 |
| Institutional Trades |
| Total Institutional Trades: |
11 |
| Avg Institutional Trade: |
$1.29M |
| Avg Institutional Trade (30 D): |
$.63M |
| Avg Institutional Trade (90 D): |
$.63M |
| Avg Institutional Trade Volume: |
.43M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.81M |
| Avg Closing Trade (30 D): |
$6.14M |
| Avg Closing Trade (90 D): |
$6.14M |
| Avg Closing Volume: |
613.68K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
$-.28
|
$-.09
|
$-.11
|
|
Diluted EPS
|
$-.28
|
$-.09
|
$-.11
|
|
Revenue
|
$41.64M
|
$10.09M
|
$9.65M
|
|
Gross Profit
|
$27.72M
|
$6.44M
|
$6.05M
|
|
Net Income / Loss
|
$-12.02M
|
$-3.66M
|
$-4.63M
|
|
Operating Income / Loss
|
$-11.87M
|
$-3.52M
|
$-4.59M
|
|
Cost of Revenue
|
$13.92M
|
$3.65M
|
$3.6M
|
|
Net Cash Flow
|
$5.86M
|
$-1.69M
|
$-5.62M
|
|
PE Ratio
|
|
|
|
|
|
|